Loading data
SHPHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 4.05 m USD | 3.62 m USD | 3.5 m USD | 1.05 m USD | 1.02 m USD |
| Operating profit | -11.92 m USD | -7.7 m USD | -5.89 m USD | -2.34 m USD | -1.74 m USD |
| Profit before tax | — | — | -6.59 m USD | -5 m USD | -1.15 m USD |
| Net income (reported basis) | -11.7 m USD | -9.14 m USD | -6.59 m USD | -5 m USD | -1.15 m USD |
| Net income attributable to common shareholders | — | — | -6.59 m USD | -6.75 m USD | -1.26 m USD |
| Basic earnings per share | -7.16 USD/share | -79.65 USD/share | -3.53 USD/share | -5.04 USD/share | -0.12 USD/share |
| Diluted earnings per share | -7.16 USD/share | -82.6 USD/share | -3.53 USD/share | -5.04 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.